Literature DB >> 4105931

Augmented anti-S 3 antibody responses to an S 3 -protein conjugate.

W E Paul, D H Katz, B Benacerraf.   

Abstract

Mesh:

Substances:

Year:  1971        PMID: 4105931

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  11 in total

Review 1.  Immunogenicity and immunochemistry of Streptococcus pneumoniae capsular polysaccharides.

Authors:  J E van Dam; A Fleer; H Snippe
Journal:  Antonie Van Leeuwenhoek       Date:  1990-06       Impact factor: 2.271

2.  Inhibitory effect of carrier and hapten preimmunization on delayed hypersensitivity to the carrier.

Authors:  P J Neveu
Journal:  Immunology       Date:  1976-08       Impact factor: 7.397

3.  The effect of passive immunization against tetanus toxoid in man.

Authors:  M Plassara; C Mandalenaki; E Papathanassiou; E Vrachnou; P Athanassiades
Journal:  Immunology       Date:  1978-09       Impact factor: 7.397

4.  Degeneracy of the immune response to sheep red cells.

Authors:  R K Gershon; K Kondo
Journal:  Immunology       Date:  1972-09       Impact factor: 7.397

5.  Antibody responses to Haemophilus influenzae type b and diphtheria toxin induced by conjugates of oligosaccharides of the type b capsule with the nontoxic protein CRM197.

Authors:  P Anderson
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Artificial Salmonella vaccines: O-antigenic oligosaccharide-protein conjugates induce protection against infection with Salmonella typhimurium.

Authors:  S B Svenson; M Nurminen; A A Lindberg
Journal:  Infect Immun       Date:  1979-09       Impact factor: 3.441

Review 7.  Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines.

Authors:  E AlonsoDeVelasco; A F Verheul; J Verhoef; H Snippe
Journal:  Microbiol Rev       Date:  1995-12

8.  Non-epitope-specific suppression of the antibody response to Haemophilus influenzae type b conjugate vaccines by preimmunization with vaccine components.

Authors:  T Barington; M Skettrup; L Juul; C Heilmann
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Enterobacterial common antigen-tetanus toxoid conjugate as immunogen.

Authors:  C Lugowski; M Kułakowska; E Romanowska
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the Haemophilus influenzae b capsular polysaccharide in human infants.

Authors:  R A Insel; P W Anderson
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.